Published December, 2014
By Mohamed Al-Rubeai
Publisher: Springer (Springer International Publishing AG)
Series: Cell Engineering
Rating:
Availability: Available

A major reference volume on cell culture research and how it impacts on production of biopharmaceutical proteins worldwide, the book is essential reading for everyone working in cell culture and is a recommended volume for all biotechnology libraries.

---

Published October, 2013
By Mohamed Al-Rubeai and Mariam Naciri
Publisher: Springer
Series: Cell Engineering
Rating:
Availability: Available

It includes chapters on neural and vascular stem vascular stem cell therapy, expansion engineering of embryonic stem cells, stem cell based production of blood cells and separation technologies for stem cells and cell therapy products.

---

Published July, 2013
By Mohamed Al-Rubeai
Publisher: Springer
Series: Cell Engineering
Rating:
Availability: Available

Engineered antibodies currently represent over 30% of biopharmaceuticals in clinical trials and their total worldwide sales continue to increase significantly. There is a strong focus on those issues related to the production of intrabodies, bispecific antibody and antibody fragments and also to novel applications in cancer immunotherapy.

---

Published November, 2012
By Mohamed Al-Rubeai
Publisher: Springer
Series: Cell Engineering
Rating:
Availability: Available

The advantages of the baculovirus system are rooted in the properties of the virus and the host (insect, or cell lines derived from it). The budded virus rapidly spreads the infection from cell to cell within the insect host, resulting ultimately in the complete liquefaction of the host, and release of occluded virus into the environment.

---

Published March, 2012
By Springer and Mohamed Al-Rubeai
Publisher: Springer
Series: Cell Engineering
Rating:
Availability: Available

This book presents an overall picture of the current state of knowledge in Cell Line Development. It offers a full review with assessments and perspectives of expression engineering and describes recent methods used to establish mammalian host cell lines.

---

Published May, 2011
By Mohamed Al-Rubeai
Publisher: Springer
Series: Cell Engineering
Rating:
Availability: Available

Engineered antibodies currently represent over 30% of biopharmaceuticals in clinical trials and their total worldwide sales continue to increase significantly. There is a strong focus on those issues related to the production of intrabodies, bispecific antibody and antibody fragments and also to novel applications in cancer immunotherapy.

---

Published December, 2010
By Mohamed Al-Rubeai
Publisher: Springer
Series: Cell Engineering
Rating:
Availability: Available

This volume, which is based on presentations at the `European Workshop on Animal Cell Engineering' held in Costa Brava, Spain, contains a collection of chapters relating to cellular function and modification by leading authorities in several different areas of basic research and the biopharmaceutical industry.

---

Published December, 2010
By Mohammed Al-Rubeai
Publisher: Springer
Series: Cell Engineering
Rating:
Availability: Available

---

Published November, 2010
By Mohamed Al-Rubeai and Martin Fussenegger
Publisher: Springer
Series: Cell Engineering
Rating:
Availability: Available

---

Published September, 2009
By Mohamed Al-Rubeai
Publisher: Springer
Series: Cell Engineering
Rating:
Availability: Available

This book presents an overall picture of the current state of knowledge in Cell Line Development. It offers a full review with assessments and perspectives of expression engineering and describes recent methods used to establish mammalian host cell lines.

---